Abstract
Cellular therapies are an emerging alternative to allogeneic corneal transplantation for endothelial dysfunction. While allogeneic transplantation is limited by donor tissue supply, current culture systems are able to produce sufficient cells from a single donor cornea to treat multiple patients. A variety of delivery systems have been developed to harness the therapeutic potential of these cultured cells. This chapter outlines these delivery techniques, including use of single cell monolayers taken directly from culture plates, implantation of cell-seeded scaffolds, both biologic and synthetic, and injection of cells into the anterior chamber.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tan DT, Dart JK, Holland EJ, et al. Corneal transplantation. Lancet. 2012;379(9827):1749–61.
Ang M, Mehta JS, Lim F, et al. Endothelial cell loss and graft survival after Descemet’s stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2012;119(11):2239–44.
Price MO, Fairchild KM, Price DA, et al. Descemet’s stripping endothelial keratoplasty five-year graft survival and endothelial cell loss. Ophthalmology. 2011;118(4):725–9.
Guerra FP, Anshu A, Price MO, et al. Descemet’s membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011;118(12):2368–73.
Ang M, Wilkins MR, Mehta JS, et al. Descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2016b;100(1):15–21.
Eye Bank Association of America. 2010; 2009 Eye Banking Statistical Report.
Eye Bank Association of America. 2016; 2015 Eye Banking Statistical Report.
Gain P, Jullienne R, He Z, et al. Global survey of corneal transplantation and eye banking. JAMA Ophthalmol. 2016;134(2):167–73.
Baum JL, Niedra R, Davis C, et al. Mass culture of human corneal endothelial cells. Arch Ophthalmol. 1979;97(6):1136–40.
Peh GS, Beuerman RW, Colman A, et al. Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview. Transplantation. 2011;91(8):811–9.
Honda N, Mimura T, Usui T, et al. Descemet stripping automated endothelial keratoplasty using cultured corneal endothelial cells in a rabbit model. Arch Ophthalmol. 2009;127(10):1321–6.
Okumura N, Sakamoto Y, Fujii K, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction. Sci Rep. 2016b;6:26113.
Koizumi N, Sakamoto Y, Okumura N, et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci. 2007;48(10):4519–26.
Koizumi N, Sakamoto Y, Okumura N, et al. Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine. Cornea. 2008;27(Suppl 1):S48–55.
Maurice DM, Giardini AA. Swelling of the cornea in vivo after the destruction of its limiting layers. Br J Ophthalmol. 1951;35(12):791–7.
Han SB, Ang H, Balehosur D, et al. A mouse model of corneal endothelial decompensation using cryoinjury. Mol Vis. 2013;19:1222–30.
Wu M, Hu ZL, Sun XM, et al. In vivo confocal microscopic evaluation of corneal endothelial dysfunction induced by phacoemulcification in rhesus monkey models. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016;38(1):42–8.
Zhang W, Hu Y, Lu L, et al. Rabbit model of corneal endothelial injury established using the Nd: YAG laser. Cornea. 2017;36(10):1274–81.
Ang M, Konstantopoulos A, Goh G, et al. Evaluation of a micro-optical coherence tomography for the corneal endothelium in an animal model. Sci Rep. 2016a;6:29769.
Kim do K, Sim BR, Khang G. Nature-derived Aloe Vera gel blended silk fibroin film scaffolds for cornea endothelial cell regeneration and transplantation. ACS Appl Mater Interfaces. 2016;8(24):15160–8.
Mimura T, Shimomura N, Usui T, et al. Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet’s membrane. Exp Eye Res. 2003;76(6):745–51.
Mimura T, Yamagami S, Usui T, et al. Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction. Exp Eye Res. 2005a;80(2):149–57.
Niu G, Choi JS, Wang Z, et al. Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation. Biomaterials. 2014;35(13):4005–14.
Okumura N, Koizumi N, Ueno M, et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol. 2012;181(1):268–77.
Zhou Y, Wu Z, Ge J, et al. Development and characterization of acellular porcine corneal matrix using sodium dodecylsulfate. Cornea. 2011;30(1):73–82.
Tuft SJ, Williams KA, Coster DJ. Endothelial repair in the rat cornea. Invest Ophthalmol Vis Sci. 1986;27(8):1199–204.
Werner L, Chew J, Mamalis N. Experimental evaluation of ophthalmic devices and solutions using rabbit models. Vet Ophthalmol. 2006;9(5):281–91.
Van Horn DL, Sendele DD, Seideman S, et al. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci. 1977;16(7):597–613.
Kimoto M, Shima N, Yamaguchi M, et al. Development of a bioengineered corneal endothelial cell sheet to fit the corneal curvature. Invest Ophthalmol Vis Sci. 2014;55(4):2337–43.
Bostan C, Theriault M, Forget KJ, et al. In vivo functionality of a corneal endothelium transplanted by cell-injection therapy in a feline model. Invest Ophthalmol Vis Sci. 2016;57(4):1620–34.
Van Horn DL, Hyndiuk RA. Endothelial wound repair in primate cornea. Exp Eye Res. 1975;21(2):113–24.
Hsiue GH, Lai JY, Chen KH, et al. A novel strategy for corneal endothelial reconstruction with a bioengineered cell sheet. Transplantation. 2006;81(3):473–6.
Sumide T, Nishida K, Yamato M, et al. Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J. 2006;20(2):392–4.
Madathil BK, Kumar PR, Kumary TV. N-isopropylacrylamide-co-glycidylmethacrylate as a thermoresponsive substrate for corneal endothelial cell sheet engineering. Biomed Res In. 2014;2014:450672.
Teichmann J, Valtink M, Gramm S, et al. Human corneal endothelial cell sheets for transplantation: thermo-responsive cell culture carriers to meet cell-specific requirements. Acta Biomater. 2013;9(2):5031–9.
Tsaousis KT, Kopsachilis N, Tsinopoulos IT, et al. In vitro study of the deturgescence ability of cultivated human corneal endothelial cells. Cornea. 2016;35(5):669–72.
Lai JY, Lu PL, Chen KH, et al. Effect of charge and molecular weight on the functionality of gelatin carriers for corneal endothelial cell therapy. Biomacromolecules. 2006;7(6):1836–44.
Lai JY, Li YT. Functional assessment of cross-linked porous gelatin hydrogels for bioengineered cell sheet carriers. Biomacromolecules. 2010;11(5):1387–97.
Lai JY, Ma DH, Lai MH, et al. Characterization of cross-linked porous gelatin carriers and their interaction with corneal endothelium: biopolymer concentration effect. PLoS One. 2013;8(1):e54058.
Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83(6):748–52.
Fan T, Ma X, Zhao J, et al. Transplantation of tissue-engineered human corneal endothelium in cat models. Mol Vis. 2013;19:400–7.
Ishino Y, Sano Y, Nakamura T, et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci. 2004;45(3):800–6.
Zhang C, Nie X, Hu D, et al. Survival and integration of tissue-engineered corneal stroma in a model of corneal ulcer. Cell Tissue Res. 2007;329(2):249–57.
Bayyoud T, Thaler S, Hofmann J, et al. Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells. Curr Eye Res. 2012;37(3):179–86.
Du L, Wu X, Pang K, et al. Histological evaluation and biomechanical characterisation of an acellular porcine cornea scaffold. Br J Ophthalmol. 2011;95(3):410–4.
Fu Y, Fan X, Chen P, et al. Reconstruction of a tissue-engineered cornea with porcine corneal acellular matrix as the scaffold. Cells Tissues Organs. 2010;191(3):193–202.
Ju C, Gao L, Wu X, et al. A human corneal endothelium equivalent constructed with acellular porcine corneal matrix. Indian J Med Res. 2012;135(6):887–94.
Yoeruek E, Bayyoud T, Maurus C, et al. Decellularization of porcine corneas and repopulation with human corneal cells for tissue-engineered xenografts. Acta Ophthalmol. 2012;90(2):e125–31.
Amano S, Shimomura N, Yokoo S, et al. Decellularizing corneal stroma using N2 gas. Mol Vis. 2008;14:878–82.
Sasaki S, Funamoto S, Hashimoto Y, et al. In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis. 2009;15:2022–8.
Pang K. Differentiation of human embryonic stem cells to corneal epithelium and endothelium like cells for cornea replacement construction. Invest Ophth Vis Sci. 2015;56:5831.
Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324(9):573–9.
Booth C, Korossis SA, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11(4):457–62.
He Z, Forest F, Bernard A, et al. Cutting and decellularization of multiple corneal stromal lamellae for the bioengineering of endothelial grafts. Invest Ophthalmol Vis Sci. 2016;57(15):6639–51.
Peh GSL, Ang HP, Lwin CN, et al. Regulatory compliant tissue-engineered human corneal endothelial grafts restore corneal function of rabbits with bullous keratopathy. Sci Rep. 2017;7(1):14149.
Jumblatt MM, Maurice DM, Schwartz BD. A gelatin membrane substrate for the transplantation of tissue cultured cells. Transplantation. 1980;29(6):498–9.
Mohay J, Lange TM, Soltau JB, et al. Transplantation of corneal endothelial cells using a cell carrier device. Cornea. 1994;13(2):173–82.
Lu PL, Lai JY, Ma DH, et al. Carbodiimide cross-linked hyaluronic acid hydrogels as cell sheet delivery vehicles: characterization and interaction with corneal endothelial cells. J Biomater Sci Polym Ed. 2008;19(1):1–18.
Watanabe R, Hayashi R, Kimura Y, et al. A novel gelatin hydrogel carrier sheet for corneal endothelial transplantation. Tissue Eng Part A. 2011;17(17–18):2213–9.
Kabosova A, Azar DT, Bannikov GA, et al. Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci. 2007;48(11):4989–99.
Merrett K, Fagerholm P, McLaughlin CR, et al. Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen. Invest Ophthalmol Vis Sci. 2008;49(9):3887–94.
Fagerholm P, Lagali NS, Ong JA, et al. Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. Biomaterials. 2014;35(8):2420–7.
Levis HJ, Peh GS, Toh KP, et al. Plastic compressed collagen as a novel carrier for expanded human corneal endothelial cells for transplantation. PLoS One. 2012;7(11):e50993.
Hayes S, Lewis P, Islam MM, et al. The structural and optical properties of type III human collagen biosynthetic corneal substitutes. Acta Biomater. 2015;25:121–30.
Kim EY, Tripathy N, Cho SA, et al. Bioengineered neo-corneal endothelium using collagen type-I coated silk fibroin film. Colloids Surf B Biointerfaces. 2015;136:394–401.
Madden PW, Lai JN, George KA, et al. Human corneal endothelial cell growth on a silk fibroin membrane. Biomaterials. 2011;32(17):4076–84.
Chen J, Yan C, Zhu M, et al. Electrospun nanofibrous SF/P(LLA-CL) membrane: a potential substratum for endothelial keratoplasty. Int J Nanomedicine. 2015;10:3337–50.
McLaughlin CR, Acosta MC, Luna C, et al. Regeneration of functional nerves within full thickness collagen-phosphorylcholine corneal substitute implants in guinea pigs. Biomaterials. 2010;31(10):2770–8.
Ozcelik B, Brown KD, Blencowe A, et al. Ultrathin chitosan-poly(ethylene glycol) hydrogel films for corneal tissue engineering. Acta Biomater. 2013;9(5):6594–605.
Wang TJ, Wang IJ, Chen S, et al. The phenotypic response of bovine corneal endothelial cells on chitosan/polycaprolactone blends. Colloids Surf B Biointerfaces. 2012a;90:236–43.
Wang TJ, Wang IJ, Lu JN, et al. Novel chitosan-polycaprolactone blends as potential scaffold and carrier for corneal endothelial transplantation. Mol Vis. 2012b;18:255–64.
Wang TJ, Wang IJ, Hu FR, et al. Applications of biomaterials in corneal endothelial tissue engineering. Cornea. 2016;35(Suppl 1):S25–30.
Salehi S, Bahners T, Gutmann J, et al. Characterization of structural, mechanical and nano-mechanical properties of electrospun PGS/PCL fibers. RSC Adv. 2014a;4(33):16951–7.
Salehi S, Fathi M, Javanmard SH, et al. Generation of PGS/PCL blend nanofibrous scaffolds mimicking corneal stroma structure. Macromol Mater Eng. 2014b;299(4):455–69.
Salehi S, Czugala M, Stafiej P, et al. Poly (glycerol sebacate)-poly (epsilon-caprolactone) blend nanofibrous scaffold as intrinsic bio- and immunocompatible system for corneal repair. Acta Biomater. 2017;50:370–80.
Rizwan M, Peh GS, Ang HP, et al. Sequentially-crosslinked bioactive hydrogels as nano-patterned substrates with customizable stiffness and degradation for corneal tissue engineering applications. Biomaterials. 2017;120:139–54.
McCulley JP, Maurice DM, Schwartz BD. Corneal endothelial transplantation. Ophthalmology. 1980;87(3):194–201.
Patel SV, Bachman LA, Hann CR, et al. Human corneal endothelial cell transplantation in a human ex vivo model. Invest Ophthalmol Vis Sci. 2009;50(5):2123–31.
Mimura T, Yokoo S, Araie M, et al. Treatment of rabbit bullous keratopathy with precursors derived from cultured human corneal endothelium. Invest Ophthalmol Vis Sci. 2005b;46(10):3637–44.
Mimura T, Yamagami S, Usui T, et al. Necessary prone position time for human corneal endothelial precursor transplantation in a rabbit endothelial deficiency model. Curr Eye Res. 2007;32(7–8):617–23.
Clement O, Siauve N, Cuenod CA, et al. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Top Magn Reson Imaging. 1998;9(3):167–82.
Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319–31.
Moysidis SN, Alvarez-Delfin K, Peschansky VJ, et al. Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells. Nanomedicine. 2015;11(3):499–509.
Bi YL, Wu MF, Lu LX, et al. Functions of corneal endothelial cells do not change after uptake of superparamagnetic iron oxide nanoparticles. Mol Med Rep. 2013;7(6):1767–72.
Okumura N, Ueno M, Koizumi N, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 2009;50(8):3680–7.
Garnock-Jones KP. Ripasudil: first global approval. Drugs. 2014;74(18):2211–5.
Okumura N, Kakutani K, Inoue R, et al. Generation and feasibility assessment of a new vehicle for cell-based therapy for treating corneal endothelial dysfunction. PLoS One. 2016a;11(6):e0158427.
Adamis AP, Filatov V, Tripathi BJ, et al. Fuchs’ endothelial dystrophy of the cornea. Surv Ophthalmol. 1993;38(2):149–68.
Rizwan M, Peh GS, Adnan K, et al. In vitro topographical model of Fuchs dystrophy for evaluation of corneal endothelial cell monolayer formation. Adv Healthc Mater. 2016;5(22):2896–910.
Lange TM, Wood TO, McLaughlin BJ. Corneal endothelial cell transplantation using Descemet’s membrane as a carrier. J Cataract Refract Surg. 1993;19(2):232–5.
Vazquez N, Rodriguez-Barrientos CA, Aznar-Cervantes SD, et al. Silk fibroin films for corneal endothelial regeneration: transplant in a rabbit Descemet membrane endothelial Keratoplasty. Invest Ophthalmol Vis Sci. 2017;58(9):3357–65.
Mimura T, Yamagami S, Yokoo S, et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci. 2004;45(9):2992–7.
Compliance Statements
J. S. Mehta, M. Lovatt, G. Peh, and S. Wahlig declare that they have no conflict of interest. All procedures performed by the authors followed and were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study. All institutional and national guidelines for the care and use of laboratory animals were followed.
Conflict of Interest: No conflicting relationship exists for any author.
Financial disclosure: No financial disclosures.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wahlig, S., Peh, G.SL., Lovatt, M., Mehta, J.S. (2019). Dysfunctional Corneal Endothelium: Delivery of Cell Therapy. In: Alió, J., Alió del Barrio, J., Arnalich-Montiel, F. (eds) Corneal Regeneration . Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-01304-2_33
Download citation
DOI: https://doi.org/10.1007/978-3-030-01304-2_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01303-5
Online ISBN: 978-3-030-01304-2
eBook Packages: MedicineMedicine (R0)